Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 23OTHER_GOV 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 5Adenocarcinoma of Lung 3Ovarian Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Salivary Gland Neoplasms 1Recurrent Squamous Cell Lung Carcinoma 1Pancreatic Neoplasms 1Neurofibrosarcoma 1Multiple Myeloma 1MET Positive 1Lymphoma, Non-Hodgkin 1Head and Neck Neoplasms 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

Cisplatin 41Radiotherapy 32Fluorouracil 14Paclitaxel 13Docetaxel 12Cetuximab 12Radiotherapy, Intensity-Modulated 9Carboplatin 8Immunohistochemistry 6Radiotherapy, Conformal 5Gene Expression Profiling 4Polymerase Chain Reaction 3In Situ Hybridization, Fluorescence 3Gemcitabine 3Chemotherapy, Adjuvant 3vandetanib 2Surgical Procedures, Operative 2Reverse Transcriptase Polymerase Chain Reaction 2Radiosurgery 2Pilocarpine 2Panitumumab 2Neoadjuvant Therapy 2Lapatinib 2Isotretinoin 2In Situ Hybridization 2Fluorodeoxyglucose F18 2Filgrastim 2Epoetin Alfa 2Drug Therapy 2Biopsy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Head and Neck Neoplasms × Erlotinib Hydrochloride × Clear all
NCT00079053 2023-08-04

Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Canadian Cancer Trials Group

Phase 1 Completed
19 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡